Literature DB >> 29894818

Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells.

Veni Bharti1, Hua Tan1, Desiree Chow2, Yiran Wang1, Pandian Nagakannan3, Eftekhar Eftekharpour3, Jun-Feng Wang4.   

Abstract

Previous studies have shown that chronic stress and chronic stress hormone treatment induce oxidative damage in rodents. Thioredoxin (Trx) is a small redox protein that plays an important role in regulation of oxidative protein cysteine modification. A Trx reduced state is maintained by thioredoxin reductase (TrxR), and the thioredoxin-interacting protein (Txnip) is an endogenous inhibitor of Trx. The purpose of this study was to investigate the effects of chronic treatment with stress hormone corticosterone on Trx, TrxR and Txnip in cultured neuronal cells. Using immunoblotting analysis we found that although chronic corticosterone treatment had no effect on Trx and TrxR protein levels, this treatment significantly increased Txnip protein levels. Using immunocytochemistry we also found that chronic corticosterone treatment increased Txnip in both nucleus and cytosol, while glucocorticoid receptor inhibitor RU486 can block corticosterone-increased Txnip protein levels. Using biotin switch, dimedone conjugation and CRISPR/Cas9 methods we found that chronic corticosterone treatment increased protein nitrosylation and sulfenylation, while knocking out Txnip blocked corticosterone-induced protein nitrosylation and sulfenylation. Since Trx can reduce cysteine oxidative protein modification such as nitrosylation and sulfenylation, our findings suggest that chronic corticosterone treatment may upregulate Txnip by targeting glucocorticoid receptor, subsequently inhibiting Trx activity and enhancing oxidative protein cysteine modification, which contributes to corticosterone-caused oxidative damage.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  corticosterone; nitrosylation; oxidative damage; sulfenylation; thioredoxin-interacting protein

Mesh:

Substances:

Year:  2018        PMID: 29894818     DOI: 10.1016/j.neuroscience.2018.06.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  2 in total

1.  Extracellular vesicles derived from M2 microglia reduce ischemic brain injury through microRNA-135a-5p/TXNIP/NLRP3 axis.

Authors:  Yue Liu; You-Ping Li; Li-Min Xiao; Li-Ke Chen; Su-Yue Zheng; Er-Ming Zeng; Chun-Hua Xu
Journal:  Lab Invest       Date:  2021-04-19       Impact factor: 5.662

2.  Upregulation of antioxidant thioredoxin by antidepressants fluoxetine and venlafaxine.

Authors:  Veni Bharti; Hua Tan; Jaspreet Deol; Zijian Wu; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2019-08-31       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.